NDC 60687-105-11 - Medroxyprogesterone Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60687-105
- Requested NDC
- 60687-105-11
- Package NDCs from labels
- 60687-105-11, 60687-105-21
- Manufacturer
- American Health Packaging
- Effective date
- 2026-09-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Medroxyprogesterone Acetate - American Health Packaging | American Health Packaging | 2026-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-105-11 | Medroxyprogesterone Acetate | 1 in 1 BLISTER PACK | TABLET | 1 | 6 | |
| 60687-105-21 | Medroxyprogesterone Acetate | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60687-105-11 | EA - Each | 60687-105 | be34f032-b2f4-40b1-9f82-5c3053843c18 | 1 | 2016-05-16 |
| 60687-105-21 | EA - Each | 60687-105 | 6e3abfcf-9406-4851-8f8c-51ec97721e1f | 1 | 2016-05-16 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MEDROXYPROGESTERONE ACETATE | ACTIVE INGREDIENT | C2QI4IOI2G | MEDROXYPROGESTERONE ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| MEDROXYPROGESTERONE | ACTIVE MOIETY | HSU1C9YRES | MEDROXYPROGESTERONE ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | MEDROXYPROGESTERONE ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | MEDROXYPROGESTERONE ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | MEDROXYPROGESTERONE ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| METHYLCELLULOSE (15 MPA.S) | INACTIVE INGREDIENT | NPU9M2E6L8 | MEDROXYPROGESTERONE ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | MEDROXYPROGESTERONE ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | MEDROXYPROGESTERONE ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | REMEDYREPACK INC. | a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0 | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | REMEDYREPACK INC. | 1020bb60-4f13-4cd7-aaa1-c556752c84b7 | 2026-08-31 | Warnings, Adverse reactions | ANDA040159 1000135 C2QI4IOI2G |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | Prasco Laboratories | 987496bf-b4b0-409b-b745-f52ed0871f4e | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Depo-Provera | MEDROXYPROGESTERONE ACETATE | Pharmacia & Upjohn Company LLC | 199cf13e-0859-4a73-9b45-e700d0cd1049 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | REMEDYREPACK INC. | e3dfd683-d44e-427b-af06-70b9b698e016 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | ANDA040159 1000114 C2QI4IOI2G |
| Provera | MEDROXYPROGESTERONE ACETATE | Pharmacia & Upjohn Company LLC | a586be28-96af-4fed-a13f-9b94fd4c7405 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 1000141 1000114 1000135 C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Preferred Pharmaceuticals Inc. | a9e05272-aa4e-4df8-b08b-481abca3e8fd | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | ANDA040159 1000141 C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Preferred Pharmaceuticals, Inc. | 37275fd0-eb24-40a4-a93f-b818bb98414e | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | ANDA040159 1000114 C2QI4IOI2G |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | Mylan Pharmaceuticals Inc. | 2627eb11-06bf-4a45-9172-094468e3ca07 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 1000141 1000114 1000135 C2QI4IOI2G |
| Prempro | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | fd0c0836-5d23-2183-da81-9dc7f4287052 | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | 5e817926-ba15-4d16-9463-88f6ff3bd3ac | 2026-02-23 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Xiromed LLC | 24544a5d-0cf5-a099-b57c-6e0843a40532 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | Amneal Pharmaceuticals LLC | 6457d70a-2f25-4935-8511-726d988f7a03 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| MEDROXYPROGESTERONE ACETATE | MEDROXYPROGESTERONE ACETATE | Eugia US LLC | 0655670a-d127-4e08-8a23-ace64b2503b2 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | 816b9fd2-bc55-496b-846a-cabe7bbdecd6 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | ANDA040159 1000114 C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Northwind Health Company, LLC | 0de6142f-a78e-ae58-e063-6394a90adff0 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA040159 1000114 C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Amphastar Pharmaceuticals, Inc. | fda1aa8a-5739-482a-b4f6-9741ef4d9977 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.